05391nam 2200709 450 991082603170332120230807215831.00-19-756291-40-19-936260-20-19-936259-9(CKB)3710000000422727(EBL)2068362(SSID)ssj0001500034(PQKBManifestationID)12569488(PQKBTitleCode)TC0001500034(PQKBWorkID)11514195(PQKB)10793574(MiAaPQ)EBC2068362(StDuBDS)EDZ0002341134(Au-PeEL)EBL2068362(CaPaEBR)ebr11064030(CaONFJC)MIL798067(OCoLC)910935513(EXLCZ)99371000000042272720150620h20152015 uy 0engur|n|---|||||txtccrTop drugs history, pharmacology, syntheses /Jie Jack LiNew York, New York :Oxford University Press,2015.©20151 online resource (219 p.)Oxford scholarship onlinePreviously issued in print: 2015.0-19-936258-0 Includes bibliographical references at the end of each chapters and index.Cover; Top Drugs History, Pharmacology, and Syntheses; Copyright; Dedication; Contents; Preface; Cardiovascular Drugs; Chapter 1: Atorvastatin Calcium (Lipitor); 1 HISTORY; 2 PHARMACOLOGY; 2.1 Mechanism of Action; 2.2 Structure-Activity Relationship; 2.3 Bioavailability, Metabolism, and Toxicology; 3 SYNTHESIS; 3.1 Discovery Route; 3.2 Process Route; 4 CONCLUDING REMARKS; 5 REFERENCES; Chapter 2: Clopidogrel Bisulfate (Plavix); 1 HISTORY; 2 PHARMACOLOGY; 2.1 Bioavailability, Metabolism, and Toxicology; 2.2 Mechanism of Action; 2.3 Structure-Activity Relationship; 3 SYNTHESIS3.1 Discovery Route3.2 Process Route; 3.3 Synthesis of Radio-labeled API; 4 CONCLUDING REMARKS; 5 REFERENCES; Chapter 3: Amlodipine (Novasc); 1 HISTORY; 2 PHARMACOLOGY; 2.1 Mechanism of Action; 2.2 Structure-Activity Relationship; 2.3 Bioavailability, Metabolism, and Toxicology; 3 SYNTHESIS; 3.1 Discovery Route; 3.2 Process Route; 4 CONCLUDING REMARKS; 5 REFERENCES; Cancer Drugs; Chapter 4: Paclitaxel (Taxol); 1 HISTORY; 2 PHARMACOLOGY; 2.1 Mechanism of Action; 2.2 Structure-Activity Relationship; 2.3 Bioavailability, Metabolism, and Toxicology; 3 PROCESS SEMI-SYNTHESIS; 4 TOTAL SYNTHESIS4.1 Holton's Synthesis4.2 Nicolaou's Synthesis; 4.3 Danishefsky's Synthesis; 4.4 Wender's Synthesis; 5 CONCLUDING REMARKS; 6 REFERENCES; Chapter 5: Imatinib Mesylate (Gleevec); 1 HISTORY; 1.1 A Brief History of Cancer Drugs; 1.2 Treatments of Chronic Myeloid Leukemia; 1.3 Protein Kinase Inhibitors; 1.4 Genesis of Gleevec; 2 PHARMACOLOGY; 2.1 Mechanism of Action; 2.2 Structure-Activity Relationship; 2.3 Bioavailability, Metabolism, and Toxicology; 3 SYNTHESIS; 3.1 Discovery Synthesis; 3.2 Process Synthesis; 4 CONCLUDING REMARKS; 5 REFERENCES; Drugs for Metabolic DiseasesChapter 6: Sitagliptin (Januvia)1 HISTORY OF DIABETES AND DIABETIC DRUGS; 1.1 Sulfonylureas; 1.2. Biguanides; 1.3 PPARγ Agonists ; 2 PHARMACOLOGY; 2.1 Mechanism of Action ; 2.2 Structure-Activity Relationship; 2.3 Bioavailability, Metabolism, and Toxicology; 3 SYNTHESES; 3.1 Discovery Synthesis; 3.2 Process/Manufacturing Synthesis; 4 CONCLUDING REMARKS; 5 REFERENCES; CNS Drugs; Chapter 7: Duloxetine Hydrochloride (Cymbalta) ; 1 HISTORY OF DEPRESSION AND ANTIDEPRESSANTS; 1.1 Monoamine Oxidase Inhibitors; 1.2 Tricyclic Antidepressants; 1.3 Selective Serotonin Reuptake Inhibitors1.4 Serotonin and Norepinephrine Reuptake Inhibitors2 PHARMACOLOGY; 2.1 Mechanism of Action; 2.2 Structure-Activity Relationship; 2.3 Bioavailability, Metabolism, and Toxicology ; 3 SYNTHESIS; 3.1 Discovery Route; 3.2 Process Route; 4 CONCLUDING REMARKS; 5 REFERENCES; Chapter 8: Olanzapine (Zyprexa) ; 1 HISTORY OF SCHIZOPHRENIA AND ANTIPSYCHOTIC DRUGS ; 1.1 Typical Antipsychotics-The First Generation; 1.2 Atypical Antipsychotics-The Second Generation; 2 PHARMACOLOGY; 2.1 Mechanism of Action; 2.2 Structure-Activity Relationship; 2.3 Bioavailability, Metabolism, and Toxicology; 3 SYNTHESIS3.1 Discovery Route'Top Drugs' provides an in-depth study on ten prominent drugs, outlining the chemistry behind each one's creation. Jie Jack Li, a medicinal chemist and an expert on drug discovery, offers a thorough analysis of the landscape of current drug development. The comprehensive text is divided by health issues, including cardiovascular, cancer, metabolic diseases, and infectious diseases. Each section features individual chapters on significant drugs, outlining the chemistry and history of the drug's discovery.Oxford scholarship online.DrugsHistoryDrugsDesignPharmaceutical chemistryDrugsHistory.DrugsDesign.Pharmaceutical chemistry.615.1MED071000SCI013060bisacshLi Jie Jack440094MiAaPQMiAaPQMiAaPQBOOK9910826031703321Top drugs4098484UNINA01494nam0 22003491i 450 UON0046709020231205105148.55383-7188-917-820160502d2006 |0itac50 bagerENGPL|||| |||||Violence and aggression in the ancient worldessays edited by Jerzy StykaKrakow : Ksiegarnia Akademicka2006226 p.21 cmPapers from a conference held September 15-17, 2005, CracowDono Prof. BaldiIT-UONSI X 3CRACOV001001UON004670732001 Classica Cracoviensia10.AGGRESSIVITA'UONC053746FIViolenzaGrecia anticaCongressiUONC089490FIViolenzaRoma anticaStoriaCongressiUONC070730FIViolenza nella letteraturaUONC018414FIPLKrakówUONL000871303.6Conflitto sociale Violenza21STYKAJerzyUONV231323Ksiegarnia AkademickaUONV269717650ITSOL20251205RICASIBA - SISTEMA BIBLIOTECARIO DI ATENEO E ARCHIVIO STORICOUONSIUON00467090SIBA - SISTEMA BIBLIOTECARIO DI ATENEO E ARCHIVIO STORICOSI X 3 CRACOV 001 SI 17382 7 Dono Prof. BaldiViolence and aggression in the ancient world1399188UNIOR